The PATH Study – CIDP Treatment with Subcutaneous Immunoglobulin
- CSL Behring is currently recruiting CIDP patients for a clinical trial. Click on the above link to access the detailed document.
- “Treatment of Chronic Inflammatory Demyelinating Polyneuropathy”
- Eliza E. Robertson, Md, PhD and Peter D. Donofrio, MD
- What constitutes a ‘Good’ recovery outcome in post-acute Guillain-Barré syndrome?
- Results of a Nationwide Survey of post-acute GBS sufferers in the United Kingdom
- European Federation of Neurological Societies/Peripheral Nerve Society Guideline on Management Of Chronic Inflammatory Demyelinating Polyradiculoneuropathy
- “Tregitope Funding Tops $3.4 Million”